Philips recall woes grow as it flags new concerns with FDA over replaced ventilators
mekcar Philips (NYSE:PHG), which has been mired with recall of its respiratory devices, informed the the U.S. Food and Drug Administration (FDA) that its Respironics Trilogy ventilators reworked as a part of a June 2021 recall have two new potential issues. The FDA said on Nov. 17 that the first issue was that the new … Read more
